Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 2.2% and the Health Care Select Sector SPDR Fund (XLV) adding 1.8%.
The iShares Biotechnology ETF (IBB) climbed 1.6%.
In corporate news, Thermo Fisher Scientific (TMO) raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.
Boston Scientific (BSX) lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.
Dr. Reddy's Laboratories (RDY) is planning to launch a cheaper version of Novo Nordisk's (NVO) weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.